Pancreas cancer, careful improvements and human connections.
作者信息
Lloyd Shane
机构信息
University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.
出版信息
J Gastrointest Oncol. 2018 Dec;9(6):979-981. doi: 10.21037/jgo.2018.09.20.
Abstract
摘要
相似文献
1
Pancreas cancer, careful improvements and human connections.
J Gastrointest Oncol. 2018 Dec;9(6):979-981. doi: 10.21037/jgo.2018.09.20.
2
Combined kidney and pancreas transplantation.
AACN Clin Issues. 1995 Feb;6(1):143-52. doi: 10.1097/00044067-199502000-00018.
3
Pancreas and pancreas-kidney transplantation.
Curr Opin Nephrol Hypertens. 1998 May;7(3):317-25. doi: 10.1097/00041552-199805000-00013.
4
Pancreas transplantation in the United States: a review.
Curr Opin Organ Transplant. 2010 Feb;15(1):93-101. doi: 10.1097/MOT.0b013e32833552d2.
5
Organisation of the human pancreas in health and in diabetes.
Diabetologia. 2020 Oct;63(10):1966-1973. doi: 10.1007/s00125-020-05203-7. Epub 2020 Sep 7.
6
A Rare Case of Early Gastric Cancer Combined with Underlying Heterotopic Pancreas.
Clin Endosc. 2018 Mar;51(2):192-195. doi: 10.5946/ce.2017.055. Epub 2017 Aug 31.
7
[Radiosurgical exploration of false cysts of the pancreas; study of their connections with the canal of Wirsung; attempted treatment by ductal drainage].
Presse Med (1893). 1957 Dec 25;65(94):2136-9.
8
Long-term results of pancreas transplantation in patients older than 50 years.
Transpl Int. 2011 Feb;24(2):136-42. doi: 10.1111/j.1432-2277.2010.01172.x. Epub 2010 Oct 13.
9
The current state of pancreas transplantation.
AACN Clin Issues. 1999 May;10(2):164-75. doi: 10.1097/00044067-199905000-00004.
10
Pancreas transplantation.
Gastroenterol Clin North Am. 2012 Mar;41(1):133-42. doi: 10.1016/j.gtc.2011.12.002. Epub 2012 Jan 4.
引用本文的文献
1
Potential factors of specialists' willingness to write editorial and commentary: a retrospective study based on 5,091 invitations.
Ann Transl Med. 2019 Dec;7(24):805. doi: 10.21037/atm.2019.12.75.
本文引用的文献
1
Advances in surgery for pancreatic cancer.
J Gastrointest Oncol. 2018 Dec;9(6):1037-1043. doi: 10.21037/jgo.2018.05.05.
2
Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle.
J Gastrointest Oncol. 2018 Dec;9(6):1014-1026. doi: 10.21037/jgo.2018.05.16.
3
Large database utilization in health outcomes research in pancreatic cancer: an update.
J Gastrointest Oncol. 2018 Dec;9(6):996-1004. doi: 10.21037/jgo.2018.05.15.
4
Daily breathing inconsistency in pancreas SBRT: a 4DCT study.
J Gastrointest Oncol. 2018 Dec;9(6):989-995. doi: 10.21037/jgo.2018.09.08.
5
Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer.
J Gastrointest Oncol. 2018 Dec;9(6):982-988. doi: 10.21037/jgo.2018.04.03.
6
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Nature. 2017 Nov 23;551(7681):512-516. doi: 10.1038/nature24462. Epub 2017 Nov 8.
7
Pancreatic cancer: yesterday, today and tomorrow.
Future Oncol. 2016 Aug;12(16):1929-46. doi: 10.2217/fon-2016-0010. Epub 2016 Jun 1.
8
Changing the course of pancreatic cancer--Focus on recent translational advances.
Cancer Treat Rev. 2016 Mar;44:17-25. doi: 10.1016/j.ctrv.2016.01.004. Epub 2016 Jan 25.
9
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
N Engl J Med. 2013 Oct 31;369(18):1691-703. doi: 10.1056/NEJMoa1304369. Epub 2013 Oct 16.
10
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.
Zotero 插件